Your partner in precision, preclinical research
Medicilon stands by our partners at every step of their drug discovery journey. With proven scientific excellence and FDA-aligned methodologies, we help biotech and pharmaceutical innovators fast-track their path from discovery to IND success.
Our Services
We offer a full range of services covering the entire preclinical drug development process
IND Enabling Package
Drug Discovery
CMC Development
Preclinical Research
Our Footprint
Global facilities servicing clients worldwide
GLP facilities
>300,000 Sq Ft
Scientists + supporting researchers
2,400+
DMPK/ADME studies
>10,000
Total clients serviced
2,000+
Compliance and Accreditations
Operating in accordance with international standards
Specialized Capabilities
End-to-End solutions for drug discovery and development
Advanced Chemical Synthesis
Providing custom synthesis, PROTAC technology, DNA-encoded library screening, and scale-up synthesis capabilities.
Comprehensive Preclinical Research
Extensive pharmacology studies with 400+ oncology and 230+ non-tumor disease models, plus GLP-compliant toxicology evaluations.
GMP-Compliant API Manufacturing
End-to-end CMC services, ensuring compliance, consistency, and scalability from early development to clinical phases.
At Medicilon, we drive innovation and efficiency in global drug development, helping clients achieve their R&D goals.
Our culture of innovation, collaboration, and a people-first approach fosters a dynamic work environment. We prioritize talent development and invest in our people, providing opportunities for sustainable growth.
